SJ

Shreshta Jain

Active Director Director DIN 11276295
DIN 11276295 First appointment Sep 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Shreshta Jain

Data last updated:

Shreshta Jain is a Director at Medicureit Devices Private Limited (since 2025) and Director at Sensicue Healthcare Private Limited (since 2025).

DIN 11276295
Primary Designation Director
First Appointment 02 Sep 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medicureit Devices Private Limited U32509KA2025PTC211902
Director08 Dec 20252025Active
Sensicue Healthcare Private Limited U86100KA2025PTC207670
Director02 Sep 20252025Active

Board colleagues of Shreshta Jain

Directorship timeline

Open interactive timeline →
Medicureit Devices Private Limited
Sensicue Healthcare Private Limited
Premium access

Shareholding and investment profile for Shreshta Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shreshta Jain

Shreshta Jain currently holds 2 directorships: Medicureit Devices Private Limited (Director, since 08 Dec 2025); Sensicue Healthcare Private Limited (Director, since 02 Sep 2025).

Shreshta Jain was first appointed on 02 Sep 2025 as Director at Sensicue Healthcare Private Limited.

The current boards of Shreshta Jain's companies include Asha Prashanth (Medicureit Devices Private Limited), Padmapriya (Sensicue Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available